BlossomHill Therapeutics

San Diego, CA · Founded 2020 · Privately Held (backing)

Operator of a biopharmaceutical company designed to develop treatments for oncology and autoimmune diseases. BlossomHill Therapeutics is based in San Diego, CA and was founded in 2020. It was valued at $413 million at its later-stage round in Dec 2025, the last priced event on record. It has raised $257 million across 4 recorded rounds; the latest was an $84.2 million later-stage round in Nov 2025.

PMV mark · valuation
$413.1M
Oct 2026
Priced at
its later-stage round
Dec 2025
Total raised
$257.1M
Last round
Later Stage VC
Nov 2025

Who backs BlossomHill Therapeutics?

10 investors
InvestorType
OrbiMedGrowth equity
Cormorant Asset ManagementVenture capital
Vivo CapitalVenture capital
BioTrack Capital—
Brahma Capital (Texas)—
Colt Ventures—
H&D Asset Management—
Hercules Bioventures—
Janus Henderson Investors—
Plaisance Capital Management—
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

BlossomHill Therapeutics investors

10 investors are on record for BlossomHill Therapeutics, including OrbiMed, Cormorant Asset Management, Vivo Capital and BioTrack Capital. The later-stage round in Nov 2025 drew 47 investors.

Free account
More of BlossomHill Therapeutics with a free account
  • ·Watch BlossomHill Therapeutics: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 10 firms already write checks for companies like BlossomHill Therapeutics. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View